REAL BROKERAGE INC/THE (REAX) Fundamental Analysis & Valuation

NASDAQ:REAX • CA75585H2063

Current stock price

2.4 USD
0 (0%)
At close:
2.45 USD
+0.05 (+2.08%)
After Hours:

This REAX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. REAX Profitability Analysis

1.1 Basic Checks

  • REAX had negative earnings in the past year.
  • In the past year REAX had a positive cash flow from operations.
  • In the past 5 years REAX always reported negative net income.
  • In the past 5 years REAX always reported a positive cash flow from operatings.
REAX Yearly Net Income VS EBIT VS OCF VS FCFREAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M

1.2 Ratios

  • REAX's Return On Assets of -6.39% is on the low side compared to the rest of the industry. REAX is outperformed by 66.67% of its industry peers.
  • REAX's Return On Equity of -15.68% is on the low side compared to the rest of the industry. REAX is outperformed by 61.90% of its industry peers.
Industry RankSector Rank
ROA -6.39%
ROE -15.68%
ROIC N/A
ROA(3y)-26.55%
ROA(5y)-31.19%
ROE(3y)-57.61%
ROE(5y)-61.83%
ROIC(3y)N/A
ROIC(5y)N/A
REAX Yearly ROA, ROE, ROICREAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 500 -500 1K

1.3 Margins

  • Looking at the Gross Margin, with a value of 8.42%, REAX is doing worse than 68.25% of the companies in the same industry.
  • REAX's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for REAX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.14%
GM growth 5Y-8.68%
REAX Yearly Profit, Operating, Gross MarginsREAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. REAX Health Analysis

2.1 Basic Checks

  • REAX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • REAX has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, REAX has more shares outstanding
  • REAX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
REAX Yearly Shares OutstandingREAX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
REAX Yearly Total Debt VS Total AssetsREAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • REAX has an Altman-Z score of 18.38. This indicates that REAX is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 18.38, REAX belongs to the top of the industry, outperforming 95.24% of the companies in the same industry.
  • REAX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 18.38
ROIC/WACCN/A
WACC8.9%
REAX Yearly LT Debt VS Equity VS FCFREAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 1.41 indicates that REAX should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.41, REAX is in line with its industry, outperforming 41.27% of the companies in the same industry.
  • A Quick Ratio of 1.41 indicates that REAX should not have too much problems paying its short term obligations.
  • REAX has a Quick ratio (1.41) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 1.41
REAX Yearly Current Assets VS Current LiabilitesREAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. REAX Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 78.57% over the past year.
  • REAX shows a strong growth in Revenue. In the last year, the Revenue has grown by 55.65%.
  • The Revenue has been growing by 159.90% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)78.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)55.65%
Revenue growth 3Y72.75%
Revenue growth 5Y159.9%
Sales Q2Q%44.07%

3.2 Future

  • REAX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 87.88% yearly.
  • Based on estimates for the next years, REAX will show a quite strong growth in Revenue. The Revenue will grow by 19.49% on average per year.
EPS Next Y32%
EPS Next 2Y87.88%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year20.68%
Revenue Next 2Y19.49%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
REAX Yearly Revenue VS EstimatesREAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
REAX Yearly EPS VS EstimatesREAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -0.05 -0.1 -0.15

More info and screens

Find the best growth stocksShow best growing peers

2

4. REAX Valuation Analysis

4.1 Price/Earnings Ratio

  • REAX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for REAX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
REAX Price Earnings VS Forward Price EarningsREAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, REAX is valued cheaper than 92.06% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.19
EV/EBITDA N/A
REAX Per share dataREAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

  • A more expensive valuation may be justified as REAX's earnings are expected to grow with 87.88% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y87.88%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. REAX Dividend Analysis

5.1 Amount

  • No dividends for REAX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

REAX Fundamentals: All Metrics, Ratios and Statistics

REAL BROKERAGE INC/THE

NASDAQ:REAX (3/19/2026, 8:26:25 PM)

After market: 2.45 +0.05 (+2.08%)

2.4

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)03-04
Earnings (Next)05-06
Inst Owners43.77%
Inst Owner Change0.14%
Ins Owners11.43%
Ins Owner ChangeN/A
Market Cap508.32M
Revenue(TTM)1.97B
Net Income(TTM)-8.11M
Analysts85.45
Price Target6.04 (151.67%)
Short Float %4.45%
Short Ratio4.47
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)69.83%
Min EPS beat(2)39.67%
Max EPS beat(2)100%
EPS beat(4)4
Avg EPS beat(4)122.06%
Min EPS beat(4)39.67%
Max EPS beat(4)292.16%
EPS beat(8)7
Avg EPS beat(8)67.19%
EPS beat(12)9
Avg EPS beat(12)40.87%
EPS beat(16)11
Avg EPS beat(16)30.12%
Revenue beat(2)2
Avg Revenue beat(2)4.36%
Min Revenue beat(2)4.31%
Max Revenue beat(2)4.42%
Revenue beat(4)4
Avg Revenue beat(4)5.71%
Min Revenue beat(4)4.24%
Max Revenue beat(4)9.88%
Revenue beat(8)8
Avg Revenue beat(8)11.02%
Revenue beat(12)12
Avg Revenue beat(12)13.96%
Revenue beat(16)16
Avg Revenue beat(16)17.61%
PT rev (1m)0%
PT rev (3m)-6.45%
EPS NQ rev (1m)-33.33%
EPS NQ rev (3m)-33.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-100%
Revenue NQ rev (1m)-0.32%
Revenue NQ rev (3m)-0.32%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.54%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.26
P/FCF 8.19
P/OCF 7.71
P/B 9.84
P/tB 13.19
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)0.29
FCFY12.21%
OCF(TTM)0.31
OCFY12.97%
SpS9.29
BVpS0.24
TBVpS0.18
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.39%
ROE -15.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 8.42%
FCFM 3.15%
ROA(3y)-26.55%
ROA(5y)-31.19%
ROE(3y)-57.61%
ROE(5y)-61.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.14%
GM growth 5Y-8.68%
F-Score7
Asset Turnover15.52
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 199.59%
Cap/Sales 0.2%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.41
Quick Ratio 1.41
Altman-Z 18.38
F-Score7
WACC8.9%
ROIC/WACCN/A
Cap/Depr(3y)110.07%
Cap/Depr(5y)167.69%
Cap/Sales(3y)0.12%
Cap/Sales(5y)0.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y32%
EPS Next 2Y87.88%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)55.65%
Revenue growth 3Y72.75%
Revenue growth 5Y159.9%
Sales Q2Q%44.07%
Revenue Next Year20.68%
Revenue Next 2Y19.49%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y63.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year803.55%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y30.18%
FCF growth 3Y138.25%
FCF growth 5YN/A
OCF growth 1Y35.29%
OCF growth 3Y122.32%
OCF growth 5YN/A

REAL BROKERAGE INC/THE / REAX Fundamental Analysis FAQ

What is the fundamental rating for REAX stock?

ChartMill assigns a fundamental rating of 4 / 10 to REAX.


Can you provide the valuation status for REAL BROKERAGE INC/THE?

ChartMill assigns a valuation rating of 2 / 10 to REAL BROKERAGE INC/THE (REAX). This can be considered as Overvalued.


Can you provide the profitability details for REAL BROKERAGE INC/THE?

REAL BROKERAGE INC/THE (REAX) has a profitability rating of 1 / 10.


What is the financial health of REAL BROKERAGE INC/THE (REAX) stock?

The financial health rating of REAL BROKERAGE INC/THE (REAX) is 7 / 10.


What is the earnings growth outlook for REAL BROKERAGE INC/THE?

The Earnings per Share (EPS) of REAL BROKERAGE INC/THE (REAX) is expected to grow by 32% in the next year.